Raleigh Jason Philip 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Jun 12, 2019
Insider Transaction Report
Form 4
Raleigh Jason Philip
Interim CFO and Treasurer
Transactions
- Exercise of In-Money
stock option
2019-06-11−9,750→ 0 totalExercise: $2.35From: 2018-06-02Exp: 2027-06-02→ common stock (9,750 underlying) - Exercise of In-Money
stock option
2019-06-10−23,405→ 0 totalExercise: $2.20From: 2019-05-31Exp: 2028-05-31→ common stock (23,405 underlying)